BACKGROUND:Colorectal cancer (CRC) is the most common cancer affecting both men and women in Australia. The illness and related treatments can cause distressing adverse effects, impact on emotional and psychological well-being, and adversely affect social, occupational, and relationship functioning. Current models of follow-up fail to address the complex needs arising after treatment completion. Strategies to better prepare and support survivors are urgently required. OBJECTIVES: This study aimed to develop and pilot test an innovative supportive care program for people with potentially curative CRC. METHODS: The SurvivorCare intervention was developed by a multidisciplinary team using 3 key principles: (1) promote patient involvement and engagement; (2) address the specific needs of individual patients, and (3) use evidence-based strategies to promote well-being and reduce treatment sequelae. It also addressed 4 essential components of survivorship planning, defined by the US Institute of Medicine. Ten survivors completed questionnaires and satisfaction interviews before and after receiving the intervention. RESULTS:SurvivorCare comprises survivorship educational materials (booklet, DVD, and question prompt list), a tailored survivorship care plan, a tailored nurse-led end-of-treatment consultation, and 3 follow-up telephone calls. Pilot data demonstrated that survivors considered the intervention appropriate, relevant, and useful. CONCLUSIONS:SurvivorCare is a well-received, comprehensive intervention that will now be evaluated in a randomized controlled trial aiming to reduce distress and unmet needs and improve quality of life in CRC survivors. IMPLICATIONS FOR PRACTICE: If SurvivorCare is shown to be effective, it will be possible to quickly and broadly disseminate this model of care.
RCT Entities:
BACKGROUND:Colorectal cancer (CRC) is the most common cancer affecting both men and women in Australia. The illness and related treatments can cause distressing adverse effects, impact on emotional and psychological well-being, and adversely affect social, occupational, and relationship functioning. Current models of follow-up fail to address the complex needs arising after treatment completion. Strategies to better prepare and support survivors are urgently required. OBJECTIVES: This study aimed to develop and pilot test an innovative supportive care program for people with potentially curative CRC. METHODS: The SurvivorCare intervention was developed by a multidisciplinary team using 3 key principles: (1) promote patient involvement and engagement; (2) address the specific needs of individual patients, and (3) use evidence-based strategies to promote well-being and reduce treatment sequelae. It also addressed 4 essential components of survivorship planning, defined by the US Institute of Medicine. Ten survivors completed questionnaires and satisfaction interviews before and after receiving the intervention. RESULTS: SurvivorCare comprises survivorship educational materials (booklet, DVD, and question prompt list), a tailored survivorship care plan, a tailored nurse-led end-of-treatment consultation, and 3 follow-up telephone calls. Pilot data demonstrated that survivors considered the intervention appropriate, relevant, and useful. CONCLUSIONS: SurvivorCare is a well-received, comprehensive intervention that will now be evaluated in a randomized controlled trial aiming to reduce distress and unmet needs and improve quality of life in CRC survivors. IMPLICATIONS FOR PRACTICE: If SurvivorCare is shown to be effective, it will be possible to quickly and broadly disseminate this model of care.
Authors: Carla Parry; Ellen Beckjord; Richard P Moser; Sana N Vieux; Lynne S Padgett; Bradford W Hesse Journal: Transl Behav Med Date: 2015-03 Impact factor: 3.046
Authors: Sarah A Birken; Sarah Raskin; Yuqing Zhang; Gema Lane; Alexandra Zizzi; Mandi Pratt-Chapman Journal: J Cancer Educ Date: 2019-06 Impact factor: 2.037
Authors: Steven C Palmer; Carrie Tompkins Stricker; SarahLena L Panzer; Sarah A Arvey; K Scott Baker; Jackie Casillas; Patricia A Ganz; Mary S McCabe; Larissa Nekhlyudov; Linda Overholser; Ann H Partridge; Betsy Risendal; Donald L Rosenstein; Karen L Syrjala; Linda A Jacobs Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Talya Salz; Mary S McCabe; Erin E Onstad; Shrujal S Baxi; Richard L Deming; Regina A Franco; Lyn A Glenn; Gregory R Harper; Alcee J Jumonville; Roxanne M Payne; Elissa A Peters; Andrew L Salner; John M Schallenkamp; Sheron R Williams; Kevin Yiee; Kevin C Oeffinger Journal: Cancer Date: 2013-12-10 Impact factor: 6.860